Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis

Keyphrases

• Adult Age 10%
• Allergen 30%
• Allergen-specific 10%
• Allergic Rhinitis 50%
• Allergic Rhinoconjunctivitis 100%
• Clinical Effect 10%
• Confidence Interval 80%
• Conjunctivitis 50%
• Daily Symptoms 20%
• Grass 50%
• House Dust 50%
• Medication Score 20%
• Mites 50%
• Monosensitized 100%
• Overall Safety 10%
• Placebo 20%
• Placebo-controlled 10%
• Pollen Season 20%
• Polysensitized 100%
• Ragweed 50%
• Rhinitis 30%
• Safety Profile 10%
• Sublingual Immunotherapy 10%
• Sublingual Immunotherapy Tablet 100%
• Symptom Score 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Allergen 50%
• Allergic Rhinitis 50%
• Dermatophagoides 50%
• Immunotherapy 100%
• Placebo 30%
• Ragweed 50%
• Rhinitis 30%
• Rhinoconjunctivitis 100%
• Rotigotine 10%
• Tablet 100%

Immunology and Microbiology

• Allergen 44%
• Allergen Immunotherapy 11%
• Allergic Rhinitis 55%
• Conjunctivitis 55%
• Dermatophagoides 55%
• Ragweed 55%
• Rhinitis 33%
• Sublingual Immunotherapy 100%